Allogeneic Transplantation for Advanced AML: The Value of Complete Remission

BACKGROUND: Patients with AML without complete remission (CR) or in first relapse (relapse1) can have extended leukemia control and survival following allogeneic hematopoietic cell transplantation (HCT). Transplantation in relapse1 or primary induction failure (PIF) versus treatment to achieve CR2 a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer
Autors principals: Weisdorf, Daniel, Millard, Heather R., Horowitz, Mary M., Hyare, Parvinder S., Champlin, Richard, Ho, Vincent, Mielcarek, Marco, Rezvani, Andrew, Stockerl-Goldstein, Keith, Khoury, Hanna J., De Lima, Marcos, Saber, Wael, Sandmaier, Brenda, Zhang, Mei Jie, Eapen, Mary
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5445001/
https://ncbi.nlm.nih.gov/pubmed/28117884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30536
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars